rss
Br J Ophthalmol 2008;92:500-504 doi:10.1136/bjo.2007.125187
  • Original Article
    • Clinical science

A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma

  1. B Siesky1,
  2. A Harris1,
  3. L B Cantor1,
  4. L Kagemann2,3,
  5. Y Weitzman4,
  6. L McCranor1,
  7. C Marques1,
  8. A Werne1,
  9. E Stefansson5
  1. 1
    Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA
  2. 2
    UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  3. 3
    Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA, USA
  4. 4
    Adom, Tel Aviv, Israel
  5. 5
    Department of Ophthalmology, University of Iceland, Reykjavik, Iceland
  1. Professor A Harris, Department of Ophthalmology, Indiana University School of Medicine, 702 Rotary Circle, Rm 137, Indianapolis, IN 46202, USA; harrisal{at}netvision.net.il
  • Accepted 28 August 2007

Abstract

Aims: To assess the effects of brinzolamide and dorzolamide on ocular haemodynamics and retinal oxygen saturation in patients with primary open-angle glaucoma (OAG).

Methods: Fifteen patients with OAG were evaluated in a randomised, cross-over, double-blind study. They were treated with either brinzolamide or dorzolamide for 3 months and then crossed-over after a 4-week washout period. They were given timolol during a 4-week run-in period and during washout. The following were performed after run-in, after washout and after each treatment period: adverse events check, measurement of visual acuity, contrast sensitivity, blood pressure, heart rate, and intraocular pressure, and fundus examination. Ocular blood flow was assessed using confocal scanning laser Doppler flowmetry (HRF) and colour Doppler imaging (CDI). Retinal oxygenation levels were determined using a non-invasive measurement of haemoglobin oxygen saturation by digital photographic fundus oximetry.

Results: Both brinzolamide and dorzolamide reduced the number of zero-flow pixels in the retina as measured by HRF, suggesting an increase in retinal blood flow (−6.86 and −0.452 respectively) with brinzolamide treatment resulting in fewer zero-flow pixels than dorzolamide (−6.41) (p = 0.024). Both brinzolamide and dorzolamide increased oxygen saturation in the retina as measured by photographic retinal oximetry in the superior (0.82 (p = 0.002) and 0.87 (p = 0.005)) and inferior (0.88 (p = 0.035) and 0.82 (p = 0.002)) retinal veins. No significant changes were found in CDI measurements of the retrobulbar blood supply during either treatment.

Conclusion: This pilot study suggests that brinzolamide and dorzolamide may increase retinal oxygen saturation in patients with OAG.

Footnotes

  • Competing interests: None declared.

  • Ethics approval: Ethics approval was obtained.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.